IL2 and neoplasm: Furthermore, the addition of IL-7 or IL-15 was shown to abrogate the suppressive activity of Tregs in vitro (28) and the administration of anti-IL-2 plus exogenous IL-15 to tumor-bearing mice enhanced the adoptive immunotherapy of tumors (29).